Premier Heart International attended ASEAN Medical Devices CEO meeting in Tokyo

Premier Heart International(PHI) attended the ASEAN CEO Business Matching Meeting for Medical Device held in Tokyo on 15-16 of March,2018.
PHI met a lot of good distributors from Indonesia, Malaysia, Thailand, Vietnam and Taiwan, and talked about sales, marketing and other business opportunities each other. This was really fruitful networking for everyone.
PHI will take advantage of these valuable opportunities for expanding MCG business into Asia.

Comments

It is challenge for conventional imaging technology to find abnormality of small vessels

The ischemic heart disease caused by stenosis is called "structural ischemia". It can be found by CAG(Coronary Angiogram) in large vessel. However, there are other cause of ischemia called "functional ischemia", which is sometimes hard to detect by imaging examination especially for small vessels. Conventional imaging examinations are not designed to detect such disease. Functional ischemia is the condition where heart muscle is less active mainly due to the supply of oxygen is insufficient by stenosis of large vessel. It is told that the blood flow of the coronary artery is said to be about 20% of the whole heart. Therefore, even if there is no stenosis in the coronary artery itself, there are cases where the cardiac function declines when the peripheral blood, inside of heart wall, inside of inner blood vessel and etc., are in poor condition. (Some of them are called "Micro-vessel disease" or "small vessel diseases") Further,

The leading cause of death for diabetics

About 422 Million adults were suffered from diabetes in 2014 worldwide, as reported by WHO in 2016. One of the leading cause of death in these patients is heart disease. According to the report, about 2.2 million deaths are from cardiovascular diseases, chronic kidney disease, and others related to higher-than-optimal blood glucose. Also, adults with diabetes have a two or three times higher rate of cardiovascular disease (CVD) than adults without diabetes. The study conducted in Japan revealed that the heart disease is the No.1 Killer of diabetes. This study follows 1939 diabetic patients in Osaka about 10 years, and the mortality rates per 1000 person-years were 31.35 for males and 21.99 for females. Among them, heart disease killed 19.5%, cerebrovascular disease 16.7% and renal disease 13.1%. Thus this study showed heart disease is the No.1 killer of diabetes. It is told that many of diabetic patients are suffered from diabetic peripheral neuropathy. In heart it is recogn

MCG study is presented at ESC Acute Cardiovascular Care 2018

MCG clinical study was presented at ESC Acute Cardiovascular Care 2018 in March 3rd, in Milan, Italy. This study was conducted in Myanmar, where the locations of the cath-lab are very limited. MCG was compared with CAG, and it showed high sensitivity and specificity for the presence of severe CAD by CAG (≥ 75%). By Author, it is evaluated as “MCG could be used for prompt detection of severe CAD in order to start appropriate (PCI/Optimal Medical Therapy) treatments in the emerging country such as Myanmar where less medical facilities and skills are available.”

Search This Blog